Patents by Inventor Peter Frederick CURWEN

Peter Frederick CURWEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neurological conditions
    Patent number: 9364534
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF or G-CSFR, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: June 14, 2016
    Assignee: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick Curwen, Eugene Maraskovsky
  • Treatment of neurological conditions
    Patent number: 9352038
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: May 31, 2016
    Assignee: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick Curwen, Eugene Maraskovsky
  • TREATMENT OF NEUROLOGICAL CONDITIONS
    Publication number: 20140234303
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Application
    Filed: March 24, 2014
    Publication date: August 21, 2014
    Applicant: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick CURWEN, Eugene MARASKOVSKY
  • TREATMENT OF NEUROLOGICAL CONDITIONS
    Publication number: 20110091456
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF or G-CSFR, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Application
    Filed: September 14, 2010
    Publication date: April 21, 2011
    Applicant: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick CURWEN, Eugene MARASKOVSKY